182 related articles for article (PubMed ID: 32519348)
1. Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
Braunstein Z; Mishra A; Staub A; Freud AG; Porcu P; Brammer JE
Br J Haematol; 2021 Feb; 192(3):484-493. PubMed ID: 32519348
[TBL] [Abstract][Full Text] [Related]
2. Large granular lymphocytic leukemia - A retrospective study of 319 cases.
Dong N; Castillo Tokumori F; Isenalumhe L; Zhang Y; Tandon A; Knepper TC; Mo Q; Shao H; Zhang L; Sokol L
Am J Hematol; 2021 Jul; 96(7):772-780. PubMed ID: 33819354
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and treatment outcomes of Asian patients with T-cell large granular lymphocytic Leukemia: a single-center analysis of 67 cases.
Park T; Byun JM; Shin DY; Koh Y; Hong J; Yoon SS; Chang YH; Kim I
Ann Hematol; 2024 Apr; 103(4):1235-1240. PubMed ID: 38062223
[TBL] [Abstract][Full Text] [Related]
4. T-cell large granular lymphocytic leukaemia: successful response to 2-deoxycoformycin.
Dincol G; Diz-Kuçukkaya R; Bicakci E
Neth J Med; 2008 Feb; 66(2):85-7. PubMed ID: 18292613
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience.
Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
Leuk Res; 2020 Mar; 90():106299. PubMed ID: 32035354
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.
Dumitriu B; Ito S; Feng X; Stephens N; Yunce M; Kajigaya S; Melenhorst JJ; Rios O; Scheinberg P; Chinian F; Keyvanfar K; Battiwalla M; Wu CO; Maric I; Xi L; Raffeld M; Muranski P; Townsley DM; Young NS; Barrett AJ; Scheinberg P
Lancet Haematol; 2016 Jan; 3(1):e22-9. PubMed ID: 26765645
[TBL] [Abstract][Full Text] [Related]
7. T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature.
Osuji N; Matutes E; Tjonnfjord G; Grech H; Del Giudice I; Wotherspoon A; Swansbury JG; Catovsky D
Cancer; 2006 Aug; 107(3):570-8. PubMed ID: 16795070
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.
Mohan SR; Clemente MJ; Afable M; Cazzolli HN; Bejanyan N; Wlodarski MW; Lichtin AE; Maciejewski JP
Haematologica; 2009 Oct; 94(10):1407-14. PubMed ID: 19794084
[TBL] [Abstract][Full Text] [Related]
9. Large granular lymphocyte leukemia: natural history and response to treatment.
Fortune AF; Kelly K; Sargent J; O'Brien D; Quinn F; Chadwick N; Flynn C; Conneally E; Browne P; Crotty GM; Thornton P; Vandenberghe E
Leuk Lymphoma; 2010 May; 51(5):839-45. PubMed ID: 20367569
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).
Sanikommu SR; Clemente MJ; Chomczynski P; Afable MG; Jerez A; Thota S; Patel B; Hirsch C; Nazha A; Desamito J; Lichtin A; Pohlman B; Sekeres MA; Radivoyevitch T; Maciejewski JP
Leuk Lymphoma; 2018 Feb; 59(2):416-422. PubMed ID: 28633612
[TBL] [Abstract][Full Text] [Related]
11. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
12. T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Aribi A; Huh Y; Keating M; O'brien S; Ferrajoli A; Faderl S; Wierda W; Kantarjian H; Ravandi F
Leuk Res; 2007 Jul; 31(7):939-45. PubMed ID: 17045649
[TBL] [Abstract][Full Text] [Related]
13. Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia.
Peng G; Yang W; Zhang L; Zhou K; Li Y; Li Y; Ye L; Li J; Fan H; Song L; Zhao X; Wu Z; Zhang F; Jing L
Hematology; 2016 Apr; 21(3):138-43. PubMed ID: 27077768
[TBL] [Abstract][Full Text] [Related]
14. T-cell large granular lymphocytic leukemia: treatment experience with fludarabine.
Costa RO; Bellesso M; Chamone DA; Ruiz MA; Hallack Neto AE; Aldred VL; Pereira J
Clinics (Sao Paulo); 2012 Jul; 67(7):745-8. PubMed ID: 22892917
[TBL] [Abstract][Full Text] [Related]
15. Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia.
Poh C; Arora M; Ghuman S; Tuscano J
Acta Haematol; 2021; 144(1):95-99. PubMed ID: 32348994
[TBL] [Abstract][Full Text] [Related]
16. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG
Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate therapy of T-cell large granular lymphocytic leukemia impact of STAT3 mutation.
Qiu ZY; Fan L; Wang R; Gale RP; Liang HJ; Wang M; Wang L; Wu YJ; Qiao C; Chen YY; Xu W; Qian J; Li JY
Oncotarget; 2016 Sep; 7(38):61419-61425. PubMed ID: 27542218
[TBL] [Abstract][Full Text] [Related]
18. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB
Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072
[TBL] [Abstract][Full Text] [Related]
19. Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series.
Lobbes H; Dervout C; Toussirot E; Felten R; Sibilia J; Wendling D; Gombert B; Ruivard M; Grobost V; Saraux A; Cornec D; Verhoeven F; Soubrier M
Semin Arthritis Rheum; 2020 Oct; 50(5):1109-1113. PubMed ID: 32920324
[TBL] [Abstract][Full Text] [Related]
20. Treatment of T-cell large granular lymphocyte leukemia with cyclosporine A: experience in a Chinese single institution.
Zhao X; Zhou K; Jing L; Zhang L; Peng G; Li Y; Ye L; Li J; Fan H; Li Y; Zhang F
Leuk Res; 2013 May; 37(5):547-51. PubMed ID: 23395383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
